stockrowCytokinetics, Incorporated (CYTK) vs Rhythm Pharmaceuticals, Inc. (RYTM)
- Cytokinetics, Incorporated CYTK 53.84 −3.08%
- Rhythm Pharmaceuticals, Inc. RYTM 112.38 +7.01%
Cytokinetics, Incorporated and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Cytokinetics, Incorporated and Rhythm Pharmaceuticals, Inc. are of similar size ($7.7B and $7.3B). Rhythm Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 61.0% against 29.9%. Rhythm Pharmaceuticals, Inc. has the higher net margin (−70.6% vs −686.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Rhythm Pharmaceuticals, Inc. leads on 11 and Cytokinetics, Incorporated on 4.
Valuation
Profitability
| Metric | CYTK | RYTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 88.23% | 65.16% |
| Operating margin | (625.15%) | (66.70%) | 0.00% |
| Net margin | (686.63%) | (70.63%) | 0.00% |
| Free cash flow margin | (519.53%) | (29.13%) | 0.00% |
| Return on equity | 184.71% | (167.49%) | (50.12%) |
| Return on assets | (47.70%) | (41.75%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack